Submit
logo

Nippon India Pharma Fund-Growth Plan-Growth Option

Category: Equity: Sectoral-Pharma and Healthcare Launch Date: 01-06-2004
AUM:

₹ 7,132.82 Cr

Expense Ratio

1.82%

Benchmark

S&P BSE Healthcare TRI

ISIN

INF204K01968

Minimum Investment

5000.0

Minimum Topup

1000.0

Minimum SIP Amount

100

Fund Manager

Sailesh Raj Bhan

Fund Performance 1Y (%) 3Y (%) 5Y (%)
Nippon India Pharma Fund-Growth Plan-Growth Option 50.74 14.42 24.41
S&P BSE Healthcare TRI 52.62 13.64 22.27
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%

Overview

NAV
428.6909
Last change
-0.91 (-0.2134%)
Fund Size (AUM)
₹ 7,132.82 Cr
Performance
20.73% (Inception)

Asset Allocation

Equity

Debt

Others

Nav Movement

Investment Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Fund Manager
Sailesh Raj Bhan
Riskometer
Very High

Top 10 Holdings

Company Holdings (%)
Sun Pharmaceutical Industries Ltd. 13.81
Lupin Ltd. 8.55
Cipla Ltd. 6.08
Apollo Hospitals Enterprise Ltd. 5.41
Divi's Laboratories Ltd. 5.05
Dr. Reddy's Laboratories Ltd. 4.78
Gland Pharma Ltd. 4.08
Others 3.92
JB Chemicals & Pharmaceuticals Ltd. 3.7
Zydus Lifesciences Ltd. 3.61

Sector Allocation

Sector Holdings (%)
Healthcare 96.17
Others 3.83

Peer Comparison

Scheme Name 5Y (%)
Nippon India Pharma Fund Gr Gr 24.41
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum 25.77
ABSL Pharma and Healthcare Reg Gr 0.0
Tata India Pharma & Healthcare Reg Gr 23.56
SBI HEALTHCARE Opportunities Reg Gr 24.87
UTI Healthcare Reg Gr 22.44
DSP Healthcare Reg Gr 27.19
Mirae Asset Healthcare Reg Gr 25.04
LIC MF Healthcare Fund Reg Gr 19.52
ITI Pharma and Healthcare Fund Reg Gr 0.0